Our History

In July 1989, the Government of Canada requested proposals for an AIDS clinical trials infrastructure. A Vancouver-based coalition of researchers responded, proposing a model of a decentralized network, built on a foundation of five regions and numerous satellite centres.

They envisioned a head office to handle the administration and house a data management centre of the highest technical capacity. The coalition developed standing committees to oversee this infrastructure and the trials it generates.

The team was confident that with Canada’s geographically diverse clinics and hospitals effectively linked, the country would be seen as an ideal place to conduct pivotal trials in HIV/AIDS.

In July 1990, the Canadian government formally announced its support for the CTN model. And, on January 23, 1991, the Network’s National Centre officially opened its doors and announced the launch of the first CTN trials.

The CTN Timeline

Latest News

Aging with HIV

| Uncategorized | No Comments

Today, more than half of all people living with HIV in Canada are 50 years or older. This is mostly because people are living much longer, healthier lives with HIV thanks to the success of antiretroviral therapy (ART).

Interpreting new international study results for the Canadian context

| Uncategorized | No Comments

CTN National Director Dr. Aslam Anis commented on new findings from study which found that the risk of transmitting HIV to a sexual partner is completely eliminated in people on ART.

Inaugural Steatohepatitis in HIV Workshop Launched

| Uncategorized | No Comments

The goal of this workshop is to provide a multidisciplinary view of the current state of nonalcoholic steatohepatitis (NASH) in HIV and establish a collaborative platform for related research projects.

Guest Blog: Dr. Kiffer G. Card

| Uncategorized | No Comments

Dr. Card, CTN Postdoctoral Fellow, provides an overview of his fellowship project, using national survey data to shed light on patterns of substance use and how they relate to HIV risk in gbMSM.